>
Switch to:

Corcept Therapeutics Price-to-Owner-Earnings

: 28.92 (As of Today)
View and export this data going back to 2004. Start your Free Trial

As of today (2021-02-25), Corcept Therapeutics's share price is $26.605000. Corcept Therapeutics's Owner Earnings per Share (TTM) ended in Dec. 2020 was $0.92. It's Price-to-Owner-Earnings for today is 28.92.


NAS:CORT' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.39   Med: 17.45   Max: 667.78
Current: 28.98

8.39
667.78

During the past 13 years, the highest Price-to-Owner-Earnings of Corcept Therapeutics was 667.78. The lowest was 8.39. And the median was 17.45.


NAS:CORT's Price-to-Owner-Earnings is ranked higher than
66% of the 163 Companies
in the Biotechnology industry.

( Industry Median: 43.28 vs. NAS:CORT: 28.98 )

As of today (2021-02-25), Corcept Therapeutics's share price is $26.605000. Corcept Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was $0.85. Therefore, Corcept Therapeutics's PE Ratio for today is 31.30.

As of today (2021-02-25), Corcept Therapeutics's share price is $26.605000. Corcept Therapeutics's EPS without NRI for the trailing twelve months (TTM) ended in was $0.85. Therefore, Corcept Therapeutics's PE Ratio without NRI for today is 31.30.

During the past 13 years, Corcept Therapeutics's highest PE Ratio without NRI was 611.58. The lowest was 9.77. And the median was 19.77.


Corcept Therapeutics Price-to-Owner-Earnings Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Corcept Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 93.08 18.72 17.91 13.75 0.00

Corcept Therapeutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.75 12.52 14.58 16.42 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Corcept Therapeutics Price-to-Owner-Earnings Distribution

* The bar in red indicates where Corcept Therapeutics's Price-to-Owner-Earnings falls into.



Corcept Therapeutics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Corcept Therapeutics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=26.605000/0.92
=28.92

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Corcept Therapeutics  (NAS:CORT) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Corcept Therapeutics Price-to-Owner-Earnings Related Terms


Corcept Therapeutics Price-to-Owner-Earnings Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)